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In recent years, considerable effort and resources have 
been expended to develop targeted gene delivery  
methods, and generation of auxotrophic mutants of 
mycobacteria. The results of these studies suggest that 
mycobacteria exhibit a wide range of recombination 
rates, which vary from loci to loci. Here we review the 
methods developed for allele exchange and targeted 
gene disruption as well as the mechanistic aspects of 
homologous recombination in mycobacteria. The results 
of whole genome, functional and structural analyses 
of Mycobacterium tuberculosis and Mycobacterium 
smegmatis RecA and SSB proteins provide insights 
into variations of the prototypic Escherichia coli 
paradigm. This variation of a common theme might 
allow mycobacteria to function in their natural but 
complex physiological environments. 
STUDIES of Mycobacterium tuberculosis are hindered by 
its long generation time (12 h), severe clumping of the 
bacilli and the safety risk involved with handling live 
cultures. Our understanding of the mechanisms of patho-
genesis caused by the tubercle bacillusis inadequate, and 
the factors responsible for virulence are poorly under-
stood. Although much research has focused on immunology, 
biochemistry, and microbiology of this pathogen, investi-
gations into molecular interactions between specific gene 
products have not been possible because of the lack of 
defined mutants with specific phenotypes. It is believed 
that transfer of DNA into tubercle bacilli, either by allele 
replacement or transposon mutagenesis would provide 
insights into understanding of the role(s) of virulence 
determinants as well as mechanisms of pathogenesis. 
Therefore, understanding of the mechanistic aspects of 
homologous recombination may help molecular g netic 
manipulation of mycobacteria as well as knowledge needed 
to develop strategies to control tuberculosis. 
Introduction of foreign DNA into mycobacteria 
Introduction of foreign DNA by transduction or conju-
gation has greatly facilitated the generation of mutant 
strains and the functional analysis of the genomes of 
Escherichia coli and Salmonella typhimurium1,2. Similarly, 
introduction of foreign DNA into mycobacterial strains 
via a genetic route has relied on the processes of trans-
formation or t ansduction. Various plasmids, derived from 
mycobacteriophages, such as TM4, L1, and D29, have 
proven useful for the development of transformation systems 
for mycobacteria3. The transfer of DNA by transduction 
by a virus was first demonstrated for M. smegmatis4,5. 
More recently, a single-step and relatively efficient allele 
exchange method was developed using a shuttle plasmid 
integrated into a specialized transducing mycobacterio-
phage TM4. This method was used to construct seven 
isogenic auxotrophic mutant strains of M. smegmatis, 
thr e substrains of M. bovis BCG and three strains of  
M. tuberculosis6. A number of investigators have ascertained 
the potential utility of this method for targeted gene 
disruptions at several loci in M. tuberculosis7–10. Myco-
bacteriophages have been used as vectors to generate 
luciferase reporter phages for the rapid detection of 
pathogenic species of mycobacteria and the assessment 
of their drug susceptibilities. 
 Bacterial conjugation is a process by which DNA is 
transferred from a donor to recipient cell through cell-t -
cell contact mediated by energy-driven transport. The 
process is conceptualized as two sub-processes: DNA pre-
paration, and mating bridge formation. Studies of con-
jugation in E. coli have played a crucial role in the 
development of bacterial genetics, and led to the isolation 
of the first recombination-deficient (rec) mutants. In  
E. coli the functions required for conjugation are mainly 
encoded by the F factor, which act at a unique cis-acting 
site to initiate and complete DNA transfer. By contrast, in 
the naturally occurring conjugation system of M. smeg-
matis, DNA transfer is chromosomally encoded11. In a di-
tion, unlike conventional plasmid transfer, recipient 
recombination functions are required to allow this plasmid, 
and derivatives of it, to re-circularize through a process 
similar to gap repair. Extended DNA homology with the 
recipient chromosome and the F factor is required to facili-
tate repair, resulting in acquisition of recipient chromo-
somal DNA by the plasmid. Together, these results show 
that DNA transfer in M. smegmatis occurs by a mechanism 
different from that of prototypical plasmid transfer 
systems11. Plasmid-mediated conjugative gene transfer 
has not been demonstrated in strains belonging to M. tuber-
culosis complex. 
Gene transfer in mycobacteria 
In recent years, considerable effort and resources have 
been expended to the dev lopment of methods for targeted *For correspondence. (e-mail: kmbc@biochem.iisc.ernet.in) 
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gene delivery and mutation in mycobacteria. The methods 
are mechanistically similar to those developed for E. coli
or yeast. Such approaches indicate that generation of gene-
tically defined isogenic strains containing single or multiple 
mutations has been hampered by the lack of suitable tools. 
M. tuberculosis and M. smegmatis genomes exhibit a 
wide range of recombination rates as reflected in the 
efficiency of allele exchange, which is known to vary 
from loci to loci. It has been technically difficult to 
generate defined auxotrphic mutants of M. tuberculosis 
at high frequency in a routine manner. Mutagenesis of 
mycobacteria has been performed by random or targeted 
strategies. In organisms in which gene targeting has been 
observed at high efficiency, DNA molecules with broken 
ends have been shown to be more recombinogenic than 
covalently closed circular DNA. However, the stimulatory 
role of double-strand breaks in mycobacteria is poorly 
understood. Historically, the first recombinant DNA 
vectors developed for mycobacteria include shuttle plasmid 
vectors and chimeric DNA molecules that replicate in  
E. coli as plasmids and in mycobacteria as phages12. 
These are integrated into the bacterial genome, by re- 
combination, so that encoded resistance genes may be  
maintained over time if the plasmid cannot replicate 
independently within that cell. The early studies of success-
ful isolation of auxotrophic mutants for the M. tuberculosis 
complex strains used insertional mutagenesis systems, 
which resulted in illegitimate recombination13, transposon 
mutagenesis14 or allele exchange15. Over the years, a variety 
of alternative gene transfer strategies have been developed 
to achieve high frequency of allele exchange in M. smeg-
matis16–20. On the other hand, similar studies in M. tuber-
culosis involving random shuttle mutagenesis using 
transposons displayed low frequency of mutations at allelic 
sites13,21,22. The difficulties encountered in these studies 
led to the conclusion that slow-growing species of myco-
bacteria promote a high frequency of illegitimate recombi-
nation13,23,24. Why is this the case? The probable answer 
stems from the fact that the methods used for detection of 
very rare allelic exchange events are hindered by low 
transformation efficiencies and high frequencies of ille-
gitimate recombination, especially in the slow-growing 
species of pathogenic mycobacteria. 
 Advances in the construction of gene targeting vectors 
together with the improvement in the delivery systems 
have led to increased efficiency of generation of ‘knockout’ 
mutants of M. tuberculosis and M. bovis BCG. These 
investigations involved short25,26 or long linear DNA 
fragments15 as substrates. Several groups have demons-
trated the use of ‘suicide’ plasmid vectors (using a non-
temperature-s nsitive plasmid) to achieve insertional 
mutagenesis in both fast- and slow-growing species of 
mycobacteria18–20,21,27–33. A two-step selection method using
selectable and counterselectable markers, positioned on 
either replicating or non-replicating plasmids, has also 
been successfully used in M. smegmatis20,32, M. bovis 
BCG and M. tuberculosis30,34–36. Interestingly, in the case 
of ‘suicide’ plasmid vectors, pretreatment of DNA with 
UV light or alkali enhanced homologous recombination 
(HR), and abolished illegitimate recombinatio in the 
recipient cells. The suicide vector approach is dependent 
upon the delivery of the gene targeting vectors by electro-
pora ion. Therefore, the HR frequencies are very close to 
the efficiency at which plasmids can be electroporated 
in o slow-growing mycobacteria, whereas the suicide 
vector approach is limited to those cases where high 
tran f rmation efficiencies can be obtained. Conseque-
tly, it is surmised that this electroporation limitation, 
r ther i efficient HR, may be the reason for difficulties 
encou tered in allele exchange experiments in slow-grow-
ing species of mycobacteria19. 
 An alternative strategy for gene targeting involves the 
use of replicating vectors. The method offers the advantage 
that high density of recombinant vectors increase the 
frequency of allele exchange, compared with that obtained 
with the suicide vectors. These vectors have greatly 
improved reproducibility of allele exchange in the slow-
growing species of mycobacteria37. The possible reasons 
are (i) the availability of increased time for HR and (ii) 
DNA replication and recombination occur concurrently 
in the cell. A further increase in the efficiency of isola-
tion of allelic replacements has been achieved by combin-
ing a counter-selection method with vectors bearing tem-
perature-sensitive origin of replication38. Recently, a 
promising method has been developed for making tar-
g t d gene knockouts in M. smegmatis and M. bovis 
BCGs based on two-plasmid incompatibility system. This 
method uses a pair of replicating plasmids carrying a 
mutated allele of a targeted gene or a transposon, and has 
the advantage by providing prolonged time for HR37. 
When used for the generation of M. smegmatis pyrF mutant 
alleles, high frequency of recombinants was obtained by 
this method. 
Analysis of M. tuberculosis and M. leprae 
genomes for rec genes 
The M. tuberculosis genome is 4.4 Mb long, which is 
exceedingly rich in genes for lipid biosynthesis and de-
gradation38. In parallel, the 3.3 Mb genome sequence of 
M. leprae has been determined39. M. tuberculosis genome 
can potentially encode 3924 genes, while the M. leprae 
encodes 1604 proteins and contains 1116 pseudogenes, 
compared to six in M. tuberculosis38,39. Comparison of 
the genome sequence of M. leprae with that of M. tuber-
culosis indicates that the former has undergone massive 
gene decay, losing large number of genes since it
divergence from a common mycobacterial ancestor40,41. It 
is possible that its genes were rendered inactive once 
their functions were no longer essential for survival, and 
this was followed by genome shrinkage through rear-
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rangements and/or deletions. It has been proposed that 
downsizing of M. leprae genome, and mutations in several 
metabolic genes, may account for its exceptionally slow 
growth as well as its failure to grow in vitro. It seems to 
have completely dispensed with or substantively reduced 
certain metabolic pathways, including oxidative and 
anaerobic respiratory chains. The enzymes for breaking 
down host-derived lipids, a means by which many myco-
bacterial pathogens derive their energy, are also drastically 
reduced in M. leprae. By contrast, most anabolic path-
ways seem to be intact, indicating that M. leprae depends 
on these pathways to survive in the nutrient-poor micro-
environment of phagosomes38–41. The availability of the 
mycobacterial genome sequences and the ability to gene-
rate transposon mutants, targeted gene disruptions, and 
complementation analyses provide an unprecedented 
opportunity for the elucidation of the functions of 
mycobacterial genes. 
 Comparative analysis of the genomes of M. tuber-
culosis and M. leprae has revealed a considerable decay 
or deletion of genes involved in recombination, especi-
ally of those encoding for alternate pathways of HR40–42. 
In E. coli, at least four alternate pathways exist for HR, 
each featuring the action of a distinct exonuclease and/or 
helicase43–44. These are required to generate 3¢ invasive 
ends for polymerization of RecA to initiate recombina-
tion. These include RecBCD, RecE/RecT or RecJ/RecQ. 
Most notably, the M. tuberculosis genome is devoid of 
homologues of E. coli recE, recT, recQ, recJ, recO and 
rusA42. RecQ helicase has been shown to disrupt 
illegitimate recombination in E. coli, and its absence 
could be one of the reasons for higher frequency of ille-
gitimate recombination in M. tuberculosis. Intriguingly, 
M. tuberculosis recB, recC and recD genes resemble 
those of Gram-negative species rather than analogues of 
addA addB that exist in Gram-positive bacteria45. M. 
leprae genome possess neither of these systems, however, 
it contains an archaeal-type exonuclease and helicase 
similar to the recB family of exonuclease/helicase. 
Mutations are also found in M. leprae genes involved in 
DNA repair (the mutT, dnaQ, alkA, dinX, and dinP 
genes)45. 
 In E. coli, early steps of HR involve RecA, RecBCD 
enzyme, and the recombination hotspot called Chi (c) 
site. E. coli c sites are G-rich (5¢-GCTGGTGG-3¢) asym-
metric cis-acting regulatory sequences that modify the 
activities of the RecBCD enzyme, thereby leading to the 
generation of single-stranded DNA. This results in pre-
ferential loading of RecA onto the c-containing DNA 
strand. The RecA nucleoprotein filament then invades 
homologous double-stranded DNA to produce a D-loop 
structure. Although recB, recC, recD genes and putative 
c-like sites have been identified in the M. uberculosis 
genome42,46, and are likely to exist in other mycobacteria, 
it has not been shown whether they constitute recombina-
tion hotspots in any of the mycobacterial species. 
Organization and expression of mycobacterial 
r cA 
The biochemical activities of many of the factors involved 
in HR in mycobacteria are poorly understood. However,
two components of the pathway of HR in mycobacteria, 
R cA and SSB, have been studied in considerable detail. 
One of the primary functions of eubacterial recA is its 
role in recombinational DNA repair43,44. Recombination 
between similar DNA sequences contributes significantly 
to genome plasticity; post-replicative mismatch repair, 
and restricts recombination between homologous seq-
uences. RecA is both ubiquitous and well conserved 
among a range of organisms. Unlike M. smegmatis, 
pathogenic species of mycobacteria display relatively low 
l v ls of HR47. In contrast to M. smegmatis recA, the M. 
tuberculosis and M. leprae recA contain an in-frame open 
reading frame encoding an intein48–49. RecA intein is 
removed from the precursor RecA by an autocatalytic 
protein splicing reaction, and active RecA is generated by 
ligation of amino- and carboxyl-terminal fragments media-
ted by intein (Figure 1). This post-tran lational process-
ing is required for RecA activity: a mutant gene that no 
longer undergoes protein splicing fails to complement E. 
coli recA mutants, whereas the wild-type gene can49. 
Therefore, it is possible that this unusual arrangement for 
the production of mature, active RecA protein might 
affect its function in M. tuberculosis, either by regulating 
the splicing reaction or by subsequent interaction of the 
intein with RecA. The biological significance of the pre-
sence of intein in the recAgene in pathogenic mycobac-
teria is the subject of the on-goi g debate47,50–52. Given 
the fact that inteins are mostly found in recA of patho-
genic mycobacteria, the advantage is unclear. Although 
the significance of recA intervening sequence is un-
known, it has been shown that M. leprae or M. tuber-
culosis recA complements M. smegmatis DrecA strains 
for recombination and UV repair50–52. 
 
Figure 1. Structural organization of E. coli, M. tuberculosis and 
M. smegmatis RecA proteins. IVS, intervening sequence. 
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 The characterization of M. tuberculosis RecA intein 
revealed that it is a unique member of the LAGLIDADG 
family of homing endonucleases53. M. tuberculosis RecA 
intein displayed very novel characteristics: In the pres-
ence of Mn2+ and ATP, it was able to cleave cognate site 
in the inteinless recA allele at 24 and 33/43 bases up-
stream of the intein insertion site, in the upper and lower 
strands respectively54. This property is consistent with 
the class of homing endonucleases that tolerate some 
sequence degeneracy within their recognition sequences53. 
Recent studies also provided a great deal of insight into 
the catalysis of DNA cleavage as well as ATPase activity 
of RecA intein55. Intriguingly, RecA intein displayed 
robust site-specific endonuclease activity with non-cog ate 
DNA in the presence of Mg2+ generating DNA fragments 
with blunt end or 1–2 base overhangs56. The latter 
activity has been implicated in the movement of RecA 
intein DNA sequence from one chromosome location to 
another in natural populations56. It is unknown whether 
M. leprae RecA intein possess similar activities. 
 In E. coli, recA is a part of the SOS response system43. 
SOS response is activated by agents or processes related 
to DNA metabolism that generate single-strand d DNA. 
The SOS box is the target for LexA binding, which exists 
upstream of all genes expressed in the SOS regulon. 
Under normal growth conditions, low levels of RecA and 
LexA exist in the cells43. LexA functions as a repressor to 
inhibit recA, lexA and many other repair operons in-
volved in the SOS response. When RecA is activated by 
DNA damage, it promotes autocatalytic cleavage of LexA. 
In M. tuberculosis, in addition to recA, a number of 
DNA-damage induced genes are regulated by LexA-
dependent mechanism57,58. However, few genes induced 
in response to DNA damage are not regulated by LexA 
binding, but by an alternate mechanism of gene regu-
lation57. Recently, it has been shown that M. tuberculosis 
recA is expressed from two promoters: one is LexA-
regulated, and the second remains DNA damage induci-
ble in the absence of RecA or when LexA binding is 
prevented59. These findings indicate that the mycobac-
terial DNA repair system is different in many aspects 
compared to the prototypic model species, e.g. E. coli or 
B. subtilis. recA deletion mutant of M. smegmatis strain 
(HS42) exhibited enhanced sensitivity to UV irradiation 
and failed to display HR34. The deficiencies in UV survi-
val and recombination were complemented by introduc-
tion of the cloned M. smegmatis recA gene34.  
Recombination activities of mycobacterial RecA 
and SSB proteins 
Recombination is central to the identification of genes 
and to the understanding of the biology of any organism. 
Using E. coli as a model, the process of HR has been 
separated into four kinetically distinguishable phases: 
presynapsis, synapsis, strand exchange and resolution43,44. 
Presynapsis involves cooperative binding of RecA 
protein on single-stranded DNA forming a helical nucleo-
protein filament; synapsis, the homologous alignme t of 
nucl oprotein filament comprised of RecA–ssDN  with 
naked duplex DNA; and unidirectional strand exchange, 
which creates long stretches of heteroduplex DNA. 
Finally, the heteroduplex DNA is expanded by RuvAB 
motor proteins and resolved by the RuvC endonuclease. 
E. coli RecA is the central component in these processes, 
and, because its functions are conserved from bacterio-
phage to humans, its study has provided a paradigm for 
understanding the biologically important process of HR. 
This complex process requires the action of > 20 gene 
products. In E. coli, the proteins that carry out all of the 
steps of HR have been purified and characterized in vitro. 
These studies are quite advanced in the case of E. coli, 
and p rtions of the HR pathway are being reconstituted 
in vitro. RecA-like proteins constitute a group of DNA 
strand transfer proteins ubiquitous in eubacteria, eukarya 
and archaea. However, the functional relationship among 
RecA-like proteins is poorly understood. 
 To understand the basis for inefficient allele exchange 
in mycobacteria compared to E. coli, to obtain gene 
targeting in mycobacteria with reasonable efficiency, and 
to u erstand the differences in allele exchange between 
M. tuberculosis and M. smegmatis, what is needed is 
greater insight into the molecular mechanism of HR in 
mycobacteria, and detailed characterization of he 
biochemical activities of the components of HR in these 
species. It is possible that the endogenous DNA repair 
and recombination machinery in mycobacteria is dif-
ferent from that of E. coli. To this end, M. tuberculosis 
RecA (38 kDa), but not its precusor (85 kDa), displayed 
th  hallmark features of E. coli RecA, including binding 
to single-stranded DNA, ssDNA-dependent ATP hydro-
lysis, formation of D-loops, homologous pairing between 
si gle-stranded DNA with duplex DNA, and strand ex-
change60,61. There were, however, striking qualitative and 
quantitative differences in the activities and pattern of 
strand exchange promoted by E. coli and M. tuberculosis 
RecA on one hand, and between M. smegmatis and M. 
tuberculosis RecA on the other60–62. These include rates 
of ssDNA-dependent ATP hydrolysis, conditions and 
cofactors required for the display of maximum homolo-
gous pairing and strand exchange. Mycobacterial RecA 
proteins promoted much slower rates of ATP hydrolysis 
than the rates of the reactions catalyzed by E. coli RecA 
in side-by-side comparisons. Results of molecular model-
ling and the crystal structure of M. tuberculosis RecA 
indicated that the reduced affinity for ATP and relative 
catalytic inefficiency of M. tuberculosis RecA is related 
to the expansion of the P-loop region, compared to its 
homologue in E. coli60. 
 Another set of observations revealed significant dif-
ferences in the pattern of homologous pairing and strand 
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exchange promoted by M. tuberculosis and M. smegmatis 
RecA proteins. M. tuberculosis RecA was able to effect 
maximum strand exchange in the alkaline pH range, 
whereas M. smegmatis RecA was around neutral pH61–63. 
Although the rates and the pH profiles of dATP hydro-
lysis catalysed by M. tuberculosis and M. smegmatis 
RecA were similar, only the latter was able to couple 
dATP hydrolysis to strand exchange. A number of studies 
have shown that single-stranded DNA binding proteins 
(SSB) serve as accessory factors in HR43,44,64. M. smeg-
matis SSB (165 aa) shares 84% identity and 89% simi-
larity with the M. tuberculosis SSB (164 aa)65. While E. 
coli RecA promoted substantial strand exchange in the 
absence of SSB, mycobacterial RecA proteins were com-
pletely unable to do so in the absence of SSB61,63. This 
finding confirmed the absolute requirement of SSB for a 
HR in M. smegmatis. Significantly, unlike E. coli SSB, 
mycobacterial SSB proteins physically interacted with 
their cognate RecA proteins with high affinity. Further, 
DNA size played an important role on the ability of 
mycobacterial RecA proteins to synthesize extended lengths 
of heteroduplex DNA. For example, with duplex DNA 
length of < 2 kb, the efficiency of strand exchange was 
indistinguishable from that of the prototype E. coli RecA, 
whereas it decreased with increase in the size of duplex 
DNA (Figure 2)61,63. E. coli RecA was able to effect 
complete strand exchange between linear duplex DNA 
(6.4 kb) and ssDNA (6407 nucleotides) to generate 
gapped or nicked circular duplex DNA. In contrast to 
this, M. tuberculosis RecA generated substantial amounts 
of intermediates and networks of DNA as the length of 
linear duplex DNA was increased from 1 kb to 6.4 kb. 
The direct correlation between the length of duplex DNA 
and accumulation of DNA intermediates and networks of 
DNA indicate that the ability of M. tuberculosis RecA to 
generate extended stretches of heteroduplex DNA is 
limited. In addition, strand exchange promoted by M. 
tuberculosis and M. smegmatis RecA displayed distinctly 
different pH profiles, suggesting functional diversity 
betwen RecA from pathogenic and non-pathogenic 
species of mycobacteria62,63. 
 
Structure of mycobacterial RecA proteins 
In the absence of DNA, the crystal structure of E. coli 
RecA revealed a central core domain and two smaller 
domains at the amino and carboxyl termini. The core 
which is made up of twisted eight stranded b-she t flan-
ked by four a-helices contains domains for DNA-
binding, designated as L1 and L2 loops, and P-loop con-
taining the nucleotide triphosphate-fold66,67. In the E. coli 
RecA crystal structure, the monomers are packed so as to 
form a right-handed helical filament with 6 monomers 
 
Figure 2. Model for the effect of the length of duplex DNA on strand exchange promoted by E. coli r M.
tuberculosis RecA. Reactions were performed with linear duplex DNA (donor; 1–6.407kb) and nucleoprotein 
filaments of RecA- ircular single-stranded DNA (recipient; 6407 nucleotide residues) as described61. ‘Plus’ symbols 
correspond to the extent of strand exchange: ‘+++’ denotes maximum s rand exchange; ‘++’ half-maximal; and ‘+’ 
one-third of the maximum value. EcRecA, E. coli RecA; MtRecA, M. tuberculosis RecA. 
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per turn66,67. The overall structures of M. tuberculosis and 
M. smegmatis RecA are nearly identical to the E. coli 
RecA structure with r.m.s. deviations of 0.6 to 1.2 Å68,69.
In comparison, the molecular surface of the M. tubercu-
losis and M. smegmatis RecA filaments possess negative 
electrostatic potential, compared to E. coli RecA (Figure 
3). The ligand-bound structures of M. tuberculosis RecA 
revealed subtle variations in nucleotide conformations. 
Furthermore, the neighbouring filaments in the bundle 
are involved in several hydrogen bonds in E. coli RecA, 
whereas are hardly any in the case of M. tuberculosis 
RecA. As a consequence, the association of filaments of 
mycobacterial RecA into bundles is much weaker. The 
DNA-binding loops, L1 and L2, were undefined in the E. 
coli RecA crystal structure. On the other hand, the 
conformation and orientation of L1 and L2 loops in the 
mycobacterial RecA structures were defined, and appear 
to be different70. More importantly, the nucleotide bind-
ing by the M. smegmatis RecA was accompanied by the 
movement of Gln196 in the L2 loop, which has been 
implicated in the propagation of the signal induced by the 
binding of nucleotide cofactor to the DNA-binding 
loops69. 
Regulation of recombination 
Recombination is vital for various cellular processes rela-
ted to DNA metabolism, but it must be tightly controlled. 
The insight into regulation of HR has been derived from 
studies on recX in eubacteria. In M. smegmatis, M. tuber-
culosis, Pseudomonas aeruginosa, Streptomyces lividans, 
or Thiobacillus ferrooxidans, the ORFs of recA and recX 
overlap and the two genes are co-transcribed71–76. It is 
known that overexpression of recA in recX mutants of S.
lividans, M. smegmatis, or P. aeruginosa, but not mutan 
RecA, lead to induction of deleterious effects72–73. How-
e r, the molecular mechanisms by which recX attenuates 
the deleterious effects induced by recA overexpression 
have remained unknown. Using M. tuberculosis as a 
odel, it has been shown that M. tuberculosis RecX 
binds directly to M. tuberculosis RecA as well as M. 
smegmatis and E. coli RecA proteins in vivo and in vitro, 
but not SSB77. The direct association of RecX with RecA 
failed to regulate the specificity or extent of binding of 
RecA ither to DNA or ATP, ligands that are central to 
activation of its functions. Significantly, RecX severely 
impeded ATP hydrolysis and the generation of hetero-
duplex DNA promoted by homologous as well as hetero-
logous RecA proteins77. These findings reveal a novel 
mode of negative regulation of RecA, and imply that 
R cX might act as an anti-recombinase to repress inap-
propriate recombinational repair events during normal 
DNA metabolism (Figure 4). Consistent with these obser-
vations, E. coli RecX was shown to inhibit strand exchange 
as well as ATPase activities of its cognate RecA78, indi-
cating that negative regulation of HR might be a general 
phenomenon. 
Perspectives 
Understanding of the biology of tubercle bacillus requires 
inputs from comparative analysis of non-pathogenic species 
of mycobacteria as well. From the earliest studies of HR, 
it was recognized that E. coli is the best model for 
 
Figure 3. Molecular surface representation of the RecA filament: a, E. coli; b, M. tuberculosis; c, M. smegmatis. 
The surfaces are colour-c ded according to the electrostatic potential: Red (negative values), blue (positive values), 
and white (neutral values). 
 
a b c 
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elucidation of the mechanism of HR at the molecular 
level. The results of whole genome, functional and 
structural analyses of M. tuberculosis and M. smegmatis 
RecA and SSB proteins provide insights into variations 
of the prototypic E. coli paradigm. This variation of a 
common theme might allow mycobacteria to function in 
their natural but complex physiological environments. 
However, further functional and structural studies will be 
required in understanding the activities of the recombi-
nation machinery as well as the mechanistic aspects of 
HR in mycobacteria. 
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